The global vaccines market is expected to reach USD 27.5 billion by 2030. Recombinant vaccines are expected to account for the largest share of the global vaccine market in terms of revenue during the forecast period owing to their high efficacy and safety profile as compared with other types of vaccines. Viral vaccines are projected to be the fastest growing segment in terms of revenue due to their ability in preventing diseases caused by viruses such as hepatitis B and influenza virus which have been responsible for significant morbidity and mortality worldwide over the past few years.
North America accounted for the largest share of global vaccine sales in 2017 owing primarily due its high prevalence rates for diseases such as measles, polio, tetanus, diphtheria and pertussis among others which necessitate vaccination against these diseases on a regular basis. The region is also home to some major players operating within this industry including Merck & Co., Inc, Pfizer Inc, Sanofi S A and GlaxoSmithKline plc among others who have been actively involved in research & development activities aimed at developing novel products that can address unmet needs within this space over recent years.
Some Of The Growth Factors Of This Market:
- Vaccines are the most cost-effective way to prevent disease and death in children under five years old, with an estimated return on investment of $16 for every dollar spent on vaccines in developing countries.
- The WHO estimates that vaccines could save 1 million lives per year if they were available for all children worldwide who need them.
- Vaccines are one of the most cost-effective health interventions and have been shown to be more cost-effective than other preventive measures such as antibiotics or insecticide-treated bed nets.
- Vaccination coverage rates have increased significantly over the past decade, but there is still a long way to go before achieving global targets.
Industry Growth Insights published a new data on “Vaccines Market”. The research report is titled “Vaccines Market research by Types (Recombinant Vaccines, Viral Vaccines, Polysaccharide Vaccines, Others, ), By Applications (Cholera, Hepatitis B, Diphtheria, Tetanus, Measles vaccine, Hepatitis A, Live attenuated influenza vaccine, Polio vaccine, Rabies vaccine, ), By Players/Companies GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, J&J(Crucell), China National Biotec, Tiantan, Hualan, Kangtai, Hissen, Jintan”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Vaccines Market Research Report
By Type
Recombinant Vaccines, Viral Vaccines, Polysaccharide Vaccines, Others,
By Application
Cholera, Hepatitis B, Diphtheria, Tetanus, Measles vaccine, Hepatitis A, Live attenuated influenza vaccine, Polio vaccine, Rabies vaccine,
By Companies
GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, J&J(Crucell), China National Biotec, Tiantan, Hualan, Kangtai, Hissen, Jintan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Vaccines Market Report Segments:
The global Vaccines market is segmented on the basis of:
Types
Recombinant Vaccines, Viral Vaccines, Polysaccharide Vaccines, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cholera, Hepatitis B, Diphtheria, Tetanus, Measles vaccine, Hepatitis A, Live attenuated influenza vaccine, Polio vaccine, Rabies vaccine,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- Sanofi
- Merck
- Pfizer
- Novartis(GSK)
- CSL
- MedImmune LLC
- J&J(Crucell)
- China National Biotec
- Tiantan
- Hualan
- Kangtai
- Hissen
- Jintan
Highlights of The Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Recombinant Vaccines
- Viral Vaccines
- Polysaccharide Vaccines
- Others
- By Application:
- Cholera
- Hepatitis B
- Diphtheria
- Tetanus
- Measles vaccine
- Hepatitis A
- Live attenuated influenza vaccine
- Polio vaccine
- Rabies vaccine
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A vaccine is a medicine or other substance that helps the body to fight an infection. Vaccines are made from pieces of the virus or bacteria that cause the infection, and they help your body learn how to defend itself against these diseases. Some vaccines are given as shots, while others may be taken by mouth (in pill form).
Some of the major players in the vaccines market are GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, J&J(Crucell), China National Biotec, Tiantan, Hualan, Kangtai, Hissen, Jintan.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Vaccines Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Vaccines Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Vaccines Market - Supply Chain
4.5. Global Vaccines Market Forecast
4.5.1. Vaccines Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Vaccines Market Size (000 Units) and Y-o-Y Growth
4.5.3. Vaccines Market Absolute $ Opportunity
5. Global Vaccines Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Vaccines Market Size and Volume Forecast by Type
5.3.1. Recombinant Vaccines
5.3.2. Viral Vaccines
5.3.3. Polysaccharide Vaccines
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Vaccines Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Vaccines Market Size and Volume Forecast by Application
6.3.1. Cholera
6.3.2. Hepatitis B
6.3.3. Diphtheria
6.3.4. Tetanus
6.3.5. Measles vaccine
6.3.6. Hepatitis A
6.3.7. Live attenuated influenza vaccine
6.3.8. Polio vaccine
6.3.9. Rabies vaccine
6.3.10.
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Vaccines Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Vaccines Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Vaccines Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Vaccines Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Vaccines Demand Share Forecast, 2019-2026
9. North America Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Vaccines Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Vaccines Market Size and Volume Forecast by Application
9.4.1. Cholera
9.4.2. Hepatitis B
9.4.3. Diphtheria
9.4.4. Tetanus
9.4.5. Measles vaccine
9.4.6. Hepatitis A
9.4.7. Live attenuated influenza vaccine
9.4.8. Polio vaccine
9.4.9. Rabies vaccine
9.4.10.
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Vaccines Market Size and Volume Forecast by Type
9.7.1. Recombinant Vaccines
9.7.2. Viral Vaccines
9.7.3. Polysaccharide Vaccines
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Vaccines Demand Share Forecast, 2019-2026
10. Latin America Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Vaccines Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Vaccines Market Size and Volume Forecast by Application
10.4.1. Cholera
10.4.2. Hepatitis B
10.4.3. Diphtheria
10.4.4. Tetanus
10.4.5. Measles vaccine
10.4.6. Hepatitis A
10.4.7. Live attenuated influenza vaccine
10.4.8. Polio vaccine
10.4.9. Rabies vaccine
10.4.10.
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Vaccines Market Size and Volume Forecast by Type
10.7.1. Recombinant Vaccines
10.7.2. Viral Vaccines
10.7.3. Polysaccharide Vaccines
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Vaccines Demand Share Forecast, 2019-2026
11. Europe Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Vaccines Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Vaccines Market Size and Volume Forecast by Application
11.4.1. Cholera
11.4.2. Hepatitis B
11.4.3. Diphtheria
11.4.4. Tetanus
11.4.5. Measles vaccine
11.4.6. Hepatitis A
11.4.7. Live attenuated influenza vaccine
11.4.8. Polio vaccine
11.4.9. Rabies vaccine
11.4.10.
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Vaccines Market Size and Volume Forecast by Type
11.7.1. Recombinant Vaccines
11.7.2. Viral Vaccines
11.7.3. Polysaccharide Vaccines
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Vaccines Demand Share, 2019-2026
12. Asia Pacific Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Vaccines Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Vaccines Market Size and Volume Forecast by Application
12.4.1. Cholera
12.4.2. Hepatitis B
12.4.3. Diphtheria
12.4.4. Tetanus
12.4.5. Measles vaccine
12.4.6. Hepatitis A
12.4.7. Live attenuated influenza vaccine
12.4.8. Polio vaccine
12.4.9. Rabies vaccine
12.4.10.
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Vaccines Market Size and Volume Forecast by Type
12.7.1. Recombinant Vaccines
12.7.2. Viral Vaccines
12.7.3. Polysaccharide Vaccines
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Vaccines Demand Share, 2019-2026
13. Middle East & Africa Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Vaccines Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Vaccines Market Size and Volume Forecast by Application
13.4.1. Cholera
13.4.2. Hepatitis B
13.4.3. Diphtheria
13.4.4. Tetanus
13.4.5. Measles vaccine
13.4.6. Hepatitis A
13.4.7. Live attenuated influenza vaccine
13.4.8. Polio vaccine
13.4.9. Rabies vaccine
13.4.10.
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Vaccines Market Size and Volume Forecast by Type
13.7.1. Recombinant Vaccines
13.7.2. Viral Vaccines
13.7.3. Polysaccharide Vaccines
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Vaccines Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Vaccines Market: Market Share Analysis
14.2. Vaccines Distributors and Customers
14.3. Vaccines Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GSK
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sanofi
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Pfizer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Novartis(GSK)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. CSL
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. MedImmune LLC
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. J&J(Crucell)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. China National Biotec
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Tiantan
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Hualan
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Kangtai
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Hissen
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Jintan
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
